Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
Scientific Reports November 18, 2021 Joseph M. Rootman, Pamela Kryskow, Kalin Harvey et al. 78 citations
Among self-selected users of a mobile app, people who microdose psychedelics (mostly psilocybin, 85%) were similar demographically to non-microdosers but more often reported a history of mental health concerns. Within that group, microdosers had lower levels of depression, anxiety, and stress across genders. Health and wellness motives were the most common reasons for microdosing, especially among women and those with mental health concerns. The findings highlight a need for rigorous longitudinal research on microdosing's mental health effects.